Creative Information Technology, Inc.

Creative Information Technology, Inc. company information, Employees & Contact Information

Who We Are Creative Information Technology, Inc. (CITI) continues to prove itself as a forward thinking information technology company, one that leverages the latest technologies to provide its clients with solutions that solve complex real-world problems. Over the last 20 years, CITI has been recognized for its dedication to customer service and commitment to innovation by many of the departments and agencies we have served in the government and commercial sectors alike. CITI has grown into a diversely talented and motivated IT enterprise with clients in the US and abroad. Game-changing technologies CITI’s core lines of business include Healthcare IT Solutions and Services, Human Services, Identity Credentialing and Access Management, Cloud and Mobile Computing, Big Data Analytics, and Business Intelligence. Investing in the future Our facilities include a state-of-the-art development integration lab and testing facility where we develop our software systems and solutions and explore the next best technologies on behalf of our customers. Government Contract Vehicles CITI holds multiple government contract vehicles that encourage a close relationship with the government agencies we support and make our products more visible. Some of the contract vehicles we hold are: GSA IT Schedule 70, NIH CIO-SP3, GSA Alliant, DHS- Eagle II, and various IT Service contracts. The CITI Advantage • CMMI Level 4 appraised • ISO 9007:27001, ISO 20000 • Oracle and Microsoft Partner • SBA Champion Award • Virginia Fantastic 50 • Inc. 500 • ACT-IAC Top 20 Excellence.Gov • ACT-IAC Igniting Innovation Award
Looking for a particular Creative Information Technology, Inc. employee's phone or email?

Creative Information Technology, Inc. Questions

News

Best Citi Credit Cards of October 2025 - US News Money

Best Citi Credit Cards of October 2025 US News Money

Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR™ Commercial Launch - PR Newswire

Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR™ Commercial Launch PR Newswire

U.S. Championships Women's 5000m Preview: Is This Josette Andrews' Moment? - Citius Mag

U.S. Championships Women's 5000m Preview: Is This Josette Andrews' Moment? Citius Mag

Citi downgrades U.S. stocks, raises China as America First fades - Fortune

Citi downgrades U.S. stocks, raises China as America First fades Fortune

Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement - PR Newswire

Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement PR Newswire

Olympic Motto - "Faster, Higher, Stronger – Together" - Olympics.com

Olympic Motto - "Faster, Higher, Stronger – Together" Olympics.com

Citius Oncology Announces Pricing of $9.0 Million Public Offering - PR Newswire

Citius Oncology Announces Pricing of $9.0 Million Public Offering PR Newswire

Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Citius Oncology, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update PR Newswire

Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2025 Financial Results and Provides Business Update PR Newswire

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update PR Newswire

Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - PR Newswire

Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025 - PR Newswire

Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025 PR Newswire

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update - PR Newswire

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update PR Newswire

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives - PR Newswire

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives PR Newswire

Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok® Program and Pathway to Approval - PR Newswire

Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok® Program and Pathway to Approval PR Newswire

Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Promising Preliminary Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab (KEYTRUDA®) and LYMPHIR™ in Cancer Patients with Recurrent Solid Tumors - PR Newswire

Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Promising Preliminary Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab (KEYTRUDA®) and LYMPHIR™ in Cancer Patients with Recurrent Solid Tumors PR Newswire

15 Parting Thoughts From The 2025 Boston Marathon - Citius Mag

15 Parting Thoughts From The 2025 Boston Marathon Citius Mag

Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences - PR Newswire

Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences PR Newswire

Citius Pharmaceuticals Announces the Closing of Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules - PR Newswire

Citius Pharmaceuticals Announces the Closing of Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules PR Newswire

Citigroup drops July rate cut bets for US, trims forecast to 75 bps - Yahoo Finance

Citigroup drops July rate cut bets for US, trims forecast to 75 bps Yahoo Finance

Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update - PR Newswire

Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update PR Newswire

Citigroup downgrades US equities, cuts S&P 500 target below 6000 on tariff concerns - Yahoo Finance

Citigroup downgrades US equities, cuts S&P 500 target below 6000 on tariff concerns Yahoo Finance

Jane Fraser | Chair of the Board and Chief Executive Officer at Citi - Citigroup

Jane Fraser | Chair of the Board and Chief Executive Officer at Citi Citigroup

The Quiet Rebuilding Of Courtney Frerichs - Citius Mag

The Quiet Rebuilding Of Courtney Frerichs Citius Mag

US regulators fine Citi $136 million for failing to fix longstanding data issues - Reuters

US regulators fine Citi $136 million for failing to fix longstanding data issues Reuters

Major Restructuring Seeks to Restore Citigroup’s Competitiveness Among US Banking Elite - International Banker

Major Restructuring Seeks to Restore Citigroup’s Competitiveness Among US Banking Elite International Banker

What Faith Kipyegon's Breaking4 Can Teach Us About Performance And Storytelling - Citius Mag

What Faith Kipyegon's Breaking4 Can Teach Us About Performance And Storytelling Citius Mag

Cencora (COR) Partners With Citius Oncology For Immunotherapy Distribution Expansion - Yahoo Finance

Cencora (COR) Partners With Citius Oncology For Immunotherapy Distribution Expansion Yahoo Finance

How Ethan Strand Learned To Win - Citius Mag

How Ethan Strand Learned To Win Citius Mag

Citi US Personal Banking turns to AI to ‘delight’ customers with personalised services - Computer Weekly

Citi US Personal Banking turns to AI to ‘delight’ customers with personalised services Computer Weekly

Matt Richtman After Winning The L.A. Marathon (2:07:56) | Race Recap, Training Approach, Strava Details - Citius Mag

Matt Richtman After Winning The L.A. Marathon (2:07:56) | Race Recap, Training Approach, Strava Details Citius Mag

Citi's real issue now is its disgruntled US investment banking MDs - eFinancialCareers

Citi's real issue now is its disgruntled US investment banking MDs eFinancialCareers

Rory Linkletter After Running 2:08:01 At Sevilla Marathon, Hits Olympic Qualifying Mark - Citius Mag

Rory Linkletter After Running 2:08:01 At Sevilla Marathon, Hits Olympic Qualifying Mark Citius Mag

Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc. - PR Newswire

Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc. PR Newswire

Get To Know CITIUS MAG Europe Correspondent David McCarthy - Citius Mag

Get To Know CITIUS MAG Europe Correspondent David McCarthy Citius Mag

Citius Pharmaceuticals regains Nasdaq compliance after 10-day streak - Investing.com

Citius Pharmaceuticals regains Nasdaq compliance after 10-day streak Investing.com

Bobby Kersee Explains Why Sydney McLaughlin-Levrone Doesn’t Race More - Citius Mag

Bobby Kersee Explains Why Sydney McLaughlin-Levrone Doesn’t Race More Citius Mag

The CITIUS MAG Podcast - Citius Mag

The CITIUS MAG Podcast Citius Mag

Citi hired a popular Goldman Sachs equities MD as it builds its US equities franchise - eFinancialCareers

Citi hired a popular Goldman Sachs equities MD as it builds its US equities franchise eFinancialCareers

An Update On The State Of CITIUS MAG + Summer 2023 Plans for U.S. Championships + World Championships - Citius Mag

An Update On The State Of CITIUS MAG + Summer 2023 Plans for U.S. Championships + World Championships Citius Mag

Citius Oncology: Is A Lymphir Launch Coming Too Late? - Seeking Alpha

Citius Oncology: Is A Lymphir Launch Coming Too Late? Seeking Alpha

Marvin Bracy Interview: How Track and Field Contracts, Appearance Fees Work - Citius Mag

Marvin Bracy Interview: How Track and Field Contracts, Appearance Fees Work Citius Mag

The Citi US Economic Surprise Index is climbing back into positive territory - TradingView

The Citi US Economic Surprise Index is climbing back into positive territory TradingView

Citi names COO of U.S. consumer bank as part of management shuffle - American Banker

Citi names COO of U.S. consumer bank as part of management shuffle American Banker

Closing the Racial Inequality Gaps - Citigroup

Closing the Racial Inequality Gaps Citigroup

CITI Healthcare Partners With Paragon Consulting Partners to Expand Enterprise EHR Deployments, Data Warehousing and Analytics in the Western United States - Newswire.com

CITI Healthcare Partners With Paragon Consulting Partners to Expand Enterprise EHR Deployments, Data Warehousing and Analytics in the Western United States Newswire.com

Citius Pharmaceuticals Acquires Dr. Reddy's Laboratories' License for Late-Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other Cancer Indications - PR Newswire

Citius Pharmaceuticals Acquires Dr. Reddy's Laboratories' License for Late-Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other Cancer Indications PR Newswire

Citius Pharma Reports Q2 2025 Financial Results - TipRanks

Citius Pharma Reports Q2 2025 Financial Results TipRanks

The Citi U.S. Economic Surprise Index Just Went Negative for the First Time Since Last June - Bloomberg.com

The Citi U.S. Economic Surprise Index Just Went Negative for the First Time Since Last June Bloomberg.com

Citi U.S. Mobile App - The Shorty Awards

Citi U.S. Mobile App The Shorty Awards

Top Creative Information Technology, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant